Condition
Richter's Transformation clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Richter's Transformation clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Japan (1), China (1)). By phase: Phase 2 (2), Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Richter's Transformation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Autologous CD45 base-edited stem cells plus CART-45 cells for relapsed or refractory hematologic cancers | Phase 1 | Philadelphia, Pennsylvania | Recruiting | Mar 5, 2026 |
| ONO-4538 treatment for Richter's transformation | Phase 2 | Nagoya, Aichi-ken and 9 other locations | Recruiting | Apr 20, 2025 |
| Evaluating Glofitamab Alone or with Other Treatments for Richter's Transformation | Phase 2 | Atlanta, Georgia and 4 other locations | Recruiting | Sep 21, 2023 |
| Treatment for B-cell malignancies using BGB-16673 | Phase 1/2 | Bengbu, Anhui and 28 other locations | Recruiting | Mar 24, 2022 |
| Registry for patients with chronic lymphocytic leukemia and related conditions | — | Dresden, Saxony | Recruiting | Aug 11, 2016 |
All recruiting trials (5)
-
Autologous CD45 base-edited stem cells plus CART-45 cells for relapsed or refractory hematologic cancers
This phase 1 study tests whether a patient’s own edited stem cells and CART-45 cells can be given safely to treat relapsed or refractory B-cell and T-cell lymphomas and Hodgkin lymphoma.
-
ONO-4538 treatment for Richter's transformation
This trial will test if the drug ONO-4538 works and is safe for people whose CLL/SLL has transformed into Richter's transformation (DLBCL- or Hodgkin-type).
-
Evaluating Glofitamab Alone or with Other Treatments for Richter's Transformation
This study is testing if a new treatment called Glofitamab, alone or with other medications, can help people with Richter's Transformation from Chronic Lymphocytic Leukemia feel better.
-
Treatment for B-cell malignancies using BGB-16673
This study is testing a new drug called BGB-16673 to see if it can safely help people with different types of B-cell cancers.
-
Registry for patients with chronic lymphocytic leukemia and related conditions
This study is tracking patients with chronic lymphocytic leukemia and similar conditions to see how well different treatments work and what long-term effects they might have.
Related topics
Quick answers
How many Richter's Transformation clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Japan (1 trial), China (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.